| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |